PRNP and diabetes mellitus: Thus, N2a cells were treated either with Phospholipase C (PLC) enzyme or Glimepiride, a sulphonylurea approved for the treatment of diabetes mellitus, inducing the release of PrPC from the surface of prion-infected neuronal cells, which releases PrPC from the surface of neuronal cells52 (see methods for details).